Medicine composition for treating benign prostatic hyperplasia

A prostatic hyperplasia and composition technology, applied in the field of drugs for the treatment of benign prostatic hyperplasia, can solve problems such as dysuria, affect the quality of life of patients, and have a lot of medicinal taste, and achieve the effects of improving quality of life, reducing residual urine volume, and stabilizing the curative effect

Active Publication Date: 2014-06-04
海门市知舟工业设计有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] BPH can cause dysuria, incessant leaching, frequent urination, increased nocturia, etc. Further development can lead to complications such as severe urinary tract infection, bladder stones, hematuria, urinary retention, renal failure, inguinal hernia, etc., seriously affecting the patient quality of life
[0004] There are many treatment methods for BPH, but there are various methods for the treatment of BPH at home and abroad, which encounter the following thorny problems: surgical treatment is traumatic, has many complications, and the elderly have poor tolerance to surgery and anesthesia
Drugs that reduce the size of the prostate, such as finasteride (Proscar), can reduce the size of the prostate, but are more expensive (9 yuan / day), and the effect is slow (starts in March); it can also cause low libido , impotence and other side effects
[0005] Although some Chinese patent medicines for the treatment of benign prostatic hyperplasia have been researched at present, they still cannot meet the needs of patients, and the composition of their prescriptions is relatively complicated, with more medicinal flavors, higher prices, and poor curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating benign prostatic hyperplasia
  • Medicine composition for treating benign prostatic hyperplasia
  • Medicine composition for treating benign prostatic hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials: 6 g of Radix Paeoniae Rubra, 3 g of Akebia, 3 g of Galla Chinensis, and 1 g of Licorice.

[0029] The above-mentioned medicinal raw materials are prepared into soft capsules, and the preparation method is as follows:

[0030] (1) Take Radix Paeoniae Rubra and Galla gall, infiltrate with water, collect the percolate, pass the percolate through the macroporous adsorption resin, first elute with water to remove impurities soluble in polar solvents, discard the water eluate Then use 80% high-concentration ethanol to elute, collect this high-concentration ethanol eluate, dry the eluate after recovering ethanol, and obtain Radix Paeoniae Rubra and Galla gallinaceus extract.

[0031] (2) Take Akebia medicinal material, crush it, and reflux extract it with 9 times the volume of 70% ethanol for 3 times, each time for 1.5 hours...

Embodiment 2

[0035] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials: 4 g of Radix Paeoniae Rubra, 2 g of Akebia, 2 g of Galla Chinensis, and 0.5 g of Radix Glycyrrhizae.

[0036] The above-mentioned medicinal raw materials are prepared into powder injection, and the preparation method is as follows:

[0037] (1) Take Radix Paeoniae Rubra and Galla gall, infiltrate with water, collect the percolate, pass the percolate through the macroporous adsorption resin, first elute with water to remove impurities soluble in polar solvents, discard the water eluate Then use 80% high-concentration ethanol to elute, collect this high-concentration ethanol eluate, dry the eluate after recovering ethanol, and obtain Radix Paeoniae Rubra and Galla gallinaceus extract.

[0038] (2) Take Akebia medicinal material, grind it, and reflux extract it with 8 times the volume of 70% ethanol for 3 times, each tim...

Embodiment 3

[0042] The pharmaceutical composition for the treatment of benign prostatic hyperplasia listed in this example consists of the following medicinal raw materials by weight: 12 g of Radix Paeoniae Rubra, 8 g of Akebia, 8 g of Galla Chinensis, and 2 g of Licorice.

[0043] The above medicinal raw materials are prepared into capsules, and the preparation method is as follows:

[0044] (1) Take Radix Paeoniae Rubra and Galla gall, infiltrate with water, collect the percolate, pass the percolate through the macroporous adsorption resin, first elute with water to remove impurities soluble in polar solvents, discard the water eluate Then use 80% high-concentration ethanol to elute, collect this high-concentration ethanol eluate, dry the eluate after recovering ethanol, and obtain Radix Paeoniae Rubra and Galla gallinaceus extract.

[0045] (2) Take Akebia medicinal material, grind it, and reflux extract it with 10 times the volume of 70% ethanol for 3 times, each time for 1.5 hours, c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating benign prostatic hyperplasia (BPH), comprising red peony root, caulis akebiae, gallnut and liquorice. The medicine composition disclosed herein can rapidly alleviate the clinical symptoms of BPH patients, and can reduce the prostate volume, and the price is low, and there is no side effect.

Description

technical field [0001] The invention relates to a medicine for treating benign prostatic hyperplasia, in particular to a pharmaceutical composition for treating benign prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia (BPH) is a common disease among elderly men, and its incidence increases with age. According to reports, the population of elderly men over 60 years old in my country has reached 150 million, and the incidence rate is 60%. Those who suffer from BPH before the age of 60, currently about 100 million people in my country suffer from BPH. [0003] BPH can cause dysuria, incessant leaching, frequent urination, increased nocturia, etc. Further development can lead to complications such as severe urinary tract infection, bladder stones, hematuria, urinary retention, renal failure, inguinal hernia, etc., seriously affecting the patient's quality of life. [0004] There are many treatment methods for BPH, but the various methods for treating BP...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/71A61P13/08
Inventor 李文军张太君张玲成建国
Owner 海门市知舟工业设计有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap